Ashurst is advising Morgan Stanley & Co. International plc ("Morgan Stanley") in relation to the £958 million offer for Vectura Group plc ("Vectura") by.
Message :
Required fields
AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on
Tuesday, June 1, 2021 at 11:30am EST.
To register in advance for the corporate presentation, sign up here.
Replay Link:
A replay will be accessible on the Events & Presentations page of the Investors section on the Company’s website at https://ir.tffpharma.com/events-and-presentations/events
About TFF Pharmaceuticals
TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that the TFF platform